Tricare to Add 'Female Viagra' to Covered Drugs List
[Mil.com] Tricare plans next week to expand its coverage of drugs used to treat premenopausal women with low sexual desire, a Tricare official said via email Thursday.
Over the last five years, the Food and Drug Administration has approved two drugs to treat women with hypoactive sexual desire disorder (HSDD): the daily pill Addyi in 2015, and a self-administered injection, Vyleesi, in 2019.
Tricare officials said they plan to add Vyleesi to the list of covered drugs beginning Feb. 19. Addyi is already covered.
Posted by: Besoeker 2020-02-17 |